Keppra 1500 mg

Pharmacokinetics of levetiracetam were also not affected by phenytoin. Valproate. KEPPRA (1500 mg twice daily) did not alter the pharmacokinetics of

KEPPRA injection is for intravenous use only and must be diluted prior to administration. One vial of KEPPRA injection contains 500 mg levetiracetam (500 mg/5 mL). See Table 1 for the recommended preparation and administration of KEPPRA injection to achieve a dose of 500 mg, 1000 mg, or 1500 mg. Table 1: Preparation And Administration Of KEPPRA

KEPPRA concentrate is an alternative for patients (adults and children to 1500 mg levetiracetam oral intake, given as three 500 mg tablets. The

See Table 1 for the recommended preparation and administration of KEPPRA injection for adults to achieve a dose of 500 mg, 1000 mg, or 1500 mg. Table 1:

KEPPRA injection is for intravenous use only and must be diluted prior to administration. One vial of KEPPRA injection contains 500 mg levetiracetam (500 mg/5 mL). See Table 1 for the recommended preparation and administration of KEPPRA injection to achieve a dose of 500 mg, 1000 mg, or 1500 mg. Table 1: Preparation And Administration Of KEPPRA

Keppra, levetiracetam-AFT. ICU INDICATIONS: Seizures and seizure 500 - 1500 mg BD. Increase to maximum dose 2024 mg BD if needed.

KEPPRA injection is for intravenous use only and must be diluted prior to administration. One vial of KEPPRA injection contains 500 mg levetiracetam (500 mg/5 mL). See Table 1 for the recommended preparation and administration of KEPPRA injection to achieve a dose of 500 mg, 1000 mg, or 1500 mg. Table 1: Preparation And Administration Of KEPPRA

levetiracetam, immediate-release tablets, liquid (Keppra). 250 to 1500 mg/day PO BID based on age and indication. 1500 mg/day. Requires Prior Authorization.

Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.